Expertise in
13
conditions

Dr. Eva I. Beaulieu

Family Medicine
Piedmont Henry Hospital
1133 Eagles Landing Pkwy, 
Stockbridge, GA 
Accepting New Patients
Offers Telehealth
Expertise in
13
conditions
Piedmont Henry Hospital
1133 Eagles Landing Pkwy, 
Stockbridge, GA 

Overview

Eva Beaulieu is a primary care provider, practicing in Family Medicine in Stockbridge, Georgia.

Dr. Beaulieu is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Sepsis, Hereditary Sensory and Autonomic Neuropathy Type 2, Congenital Insensitivity to Pain with Anhidrosis, Infantile Axonal Neuropathy, and Endoscopy.

She is actively involved in clinical research, participating in 8 clinical trials. Dr. Beaulieu is currently accepting new patients.

Specialties

Family Medicine

Licenses

Internal Medicine in GA

Hospital Affiliations

Phoebe Putney Memorial Hospital
Upson Regional Medical Center
Atrium Health Navicent The Medical Center

Languages Spoken

English
Amharic
Arabic
Bengali
French

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 20 Less Insurance Carriers -

Locations

Piedmont Henry Hospital
1133 Eagles Landing Pkwy, Stockbridge, GA 30281
Other Locations
HCA Houston Healthcare Conroe
504 Medical Center Blvd, Conroe, TX 77304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Daniel M. Halperin
Family Medicine
Expertise in
8
conditions
Dr. Daniel M. Halperin
Family Medicine
Before you request

Winship Cancer Institute Of Emory University

36 Linden Ave NE, 
Atlanta, GA 
 (20.2 miles away)
404-778-1900
Languages Spoken:
English
See accepted insurances

Daniel Halperin is a primary care provider, practicing in Family Medicine in Atlanta, Georgia. Dr. Halperin is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, and Metastatic Insulinoma. Dr. Halperin is board certified in American Board Of Internal Medicine - Medical Oncology, 2015.

Expertise in
6
conditions
Expertise in
6
conditions

US Centers For Disease Control And Prevention

1600 Clifton Rd NE, 
Atlanta, GA 
 (20.7 miles away)
404-639-1744
Languages Spoken:
English

Eduardo Azziz-Baumgartner is a primary care provider, practicing in Family Medicine in Atlanta, Georgia. Dr. Azziz-Baumgartner is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Flu, Avian Influenza, Severe Acute Respiratory Syndrome (SARS), and Pneumonia.

Expertise in
162
conditions
Dr. Terence A. Frinks
Family Medicine
Expertise in
162
conditions
Dr. Terence A. Frinks
Family Medicine
Before you request

Common Earthling

3715 Northside Pkwy NW, 
Atlanta, GA 
 (26.7 miles away)
770-938-1757
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Terence Frinks is a primary care provider, practicing in Family Medicine in Atlanta, Georgia. Dr. Frinks is highly rated in 162 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, Thromboangiitis Obliterans, and Dementia. Dr. Frinks is currently accepting new patients.

Frequently Asked Questions about Dr. Eva I. Beaulieu

How do I make an appointment with Dr. Eva I. Beaulieu?

You can book an appointment with Dr. Eva I. Beaulieu by calling their office at 678-604-5901. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Eva I. Beaulieu a top-rated expert for Sepsis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Eva I. Beaulieu is classified as an Distinguished expert for Sepsis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Eva I. Beaulieu specialize in?

While Dr. Eva I. Beaulieu is a Family Medicine, they have specific expertise in Sepsis, Hereditary Sensory and Autonomic Neuropathy Type 2, and Congenital Insensitivity to Pain with Anhidrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Eva I. Beaulieu accept my insurance?

Dr. Eva I. Beaulieu accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 678-604-5901 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Beaulieu's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 87 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile